300314 戴维医疗
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.22313.2839.5008.25215.282
总资产报酬率 ROA (%)2.78311.2398.0847.04213.050
投入资产回报率 ROIC (%)3.14412.8359.1727.98214.960

边际利润分析
销售毛利率 (%)58.52658.19558.55261.57258.637
营业利润率 (%)28.64227.71622.13518.39732.164
息税前利润/营业总收入 (%)26.84023.65917.80518.43632.105
净利润/营业总收入 (%)24.53323.87419.23916.91729.637

收益指标分析
经营活动净收益/利润总额(%)104.33988.26897.45678.79766.830
价值变动净收益/利润总额(%)-5.7506.974-4.36119.12331.859
营业外收支净额/利润总额(%)-0.132-3.092-0.084-0.039-0.784

偿债能力分析
流动比率 (X)6.4205.0265.2255.2834.843
速动比率 (X)5.3454.2194.3854.4324.215
资产负债率 (%)11.98015.32715.45714.3060.150
带息债务/全部投入资本 (%)1.1451.5372.6332.2923.615
股东权益/带息债务 (%)8,540.6836,336.4513,639.9624,244.9632,659.477
股东权益/负债合计 (%)734.736552.428546.943599.012565.499
利息保障倍数 (X)-15.213-7.335-4.130400.375167.528

营运能力分析
应收账款周转天数 (天)20.66111.89611.67911.73312.895
存货周转天数 (天)224.223214.236245.152238.880184.544